GR3034628T3 - Immunomodulators - Google Patents

Immunomodulators

Info

Publication number
GR3034628T3
GR3034628T3 GR20000402314T GR20000402314T GR3034628T3 GR 3034628 T3 GR3034628 T3 GR 3034628T3 GR 20000402314 T GR20000402314 T GR 20000402314T GR 20000402314 T GR20000402314 T GR 20000402314T GR 3034628 T3 GR3034628 T3 GR 3034628T3
Authority
GR
Greece
Prior art keywords
immunomodulators
Prior art date
Application number
GR20000402314T
Other languages
English (en)
Inventor
Larsen Christian Groenhoej
Borbala Gesser
Original Assignee
Steeno Res Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Res Group As filed Critical Steeno Res Group As
Publication of GR3034628T3 publication Critical patent/GR3034628T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20000402314T 1994-07-05 2000-10-16 Immunomodulators GR3034628T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05
PCT/DK1995/000227 WO1996001318A1 (en) 1994-07-05 1995-06-07 Immunomodulators

Publications (1)

Publication Number Publication Date
GR3034628T3 true GR3034628T3 (en) 2001-01-31

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402314T GR3034628T3 (en) 1994-07-05 2000-10-16 Immunomodulators

Country Status (28)

Country Link
US (3) US6159937A (el)
EP (2) EP0769054B1 (el)
JP (1) JPH10502249A (el)
CN (1) CN1216992C (el)
AP (1) AP690A (el)
AT (1) ATE195003T1 (el)
AU (1) AU686816B2 (el)
BR (1) BR9508243A (el)
CA (1) CA2194444C (el)
CZ (1) CZ1497A3 (el)
DE (1) DE69518156T2 (el)
DK (1) DK0769054T3 (el)
EE (1) EE03451B1 (el)
ES (1) ES2148525T3 (el)
FI (1) FI970009A (el)
GR (1) GR3034628T3 (el)
HK (1) HK1012416A1 (el)
HU (1) HU220344B (el)
MX (1) MX9606537A (el)
NO (1) NO970020L (el)
NZ (1) NZ287406A (el)
PL (1) PL181042B1 (el)
PT (1) PT769054E (el)
RO (1) RO118758B1 (el)
RU (1) RU2218348C2 (el)
SK (1) SK283096B6 (el)
UA (1) UA57702C2 (el)
WO (1) WO1996001318A1 (el)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
EP0906117A1 (en) * 1996-05-02 1999-04-07 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
CA2316296A1 (en) * 1997-10-10 1999-04-22 Imperial College Of Science, Technology And Medicine Use of csaidtm compounds for the management of uterine contractions
EP1140142A2 (en) * 1998-12-22 2001-10-10 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
CA2373588A1 (en) * 1999-05-25 2000-11-30 Canji, Inc. Gene therapy of pulmonary disease
EP1404359A2 (en) * 2000-12-07 2004-04-07 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
WO2003068152A2 (en) * 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
CA2477780A1 (en) * 2002-03-05 2003-09-18 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
EP2266606B1 (en) * 2003-05-15 2014-09-10 Genentech, Inc. Methods and compositions for the prevention and treatment of sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
CA2548220A1 (en) * 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Use of mda-7 to inhibit infection by pathogenic organisms
WO2005087793A2 (en) 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
WO2006063028A2 (en) * 2004-12-07 2006-06-15 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
KR101379364B1 (ko) * 2005-02-08 2014-03-31 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 암 치료를 위한 ｍｄａ-7을 포함하는 조성물
WO2006119170A2 (en) * 2005-05-02 2006-11-09 Avigen, Inc. Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
EP2816118B1 (en) 2005-05-31 2018-10-17 The Regents of the University of Colorado, a body corporate Methods for delivering genes
RU2009101783A (ru) * 2006-06-21 2010-07-27 Апогеникс Гмбх (De) Дифференциальная экспрессия цитокинов il-4 и/или il-10 в злокачественной опухоли человека
EP2049147A2 (en) * 2006-07-06 2009-04-22 Apogenix GmbH Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
WO2011047097A2 (en) 2009-10-13 2011-04-21 Sigalov Alexander B Inhibition of trem receptor signaling with peptide variants
RU2013145283A (ru) * 2011-03-14 2015-04-20 Флого АпС Новые антагонисты рецептора интерлейкина-1
US10167335B2 (en) 2012-02-13 2019-01-01 Agency For Science, Technology And Research IL-1β neutralizing human monoclonal antibodies
HUE046944T2 (hu) 2013-07-18 2020-03-30 Xalud Therapeutics Inc Készítmény gyulladásos ízületi betegség kezelésére
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
US20180206726A1 (en) 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
US11596670B2 (en) 2017-03-30 2023-03-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist
WO2020106754A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
WO2020158858A1 (ja) * 2019-01-31 2020-08-06 積水メディカル株式会社 生物学的試料中の遊離ａｉｍの免疫学的分析方法及び対象におけるｎａｓｈの検出方法
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
ATE187336T1 (de) * 1991-08-06 1999-12-15 Schering Corp Verwendung von interleukin-10 analogen oder antagonisten zur behandlung von endotoxin- oder superantigen induzierter toxizität
ZA931489B (en) * 1992-03-04 1993-10-28 Schering Corp Use of interleuken-10 to suppress graft-vs-host disease
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
HU220103B (hu) * 1992-08-20 2001-10-28 Schering-Plough Corp. IL-10 új alkalmazása
WO1995003411A1 (en) * 1993-07-26 1995-02-02 Schering Corporation Agonists and antagonists of human interleukin-10

Also Published As

Publication number Publication date
AP9700962A0 (en) 1997-04-30
US6168791B1 (en) 2001-01-02
PL319429A1 (en) 1997-08-04
EP0769054B1 (en) 2000-07-26
AP690A (en) 1998-10-16
HU9603615D0 (en) 1997-02-28
RO118758B1 (ro) 2003-10-30
MX9606537A (es) 1997-12-31
HU220344B (hu) 2001-12-28
EP1013764A1 (en) 2000-06-28
CA2194444C (en) 2003-01-14
SK283096B6 (sk) 2003-02-04
CA2194444A1 (en) 1996-01-18
AU686816B2 (en) 1998-02-12
AU2612195A (en) 1996-01-25
EP0769054A1 (en) 1997-04-23
EE03451B1 (et) 2001-06-15
DK0769054T3 (da) 2000-11-13
JPH10502249A (ja) 1998-03-03
UA57702C2 (uk) 2003-07-15
CN1159830A (zh) 1997-09-17
US6599501B1 (en) 2003-07-29
HK1012416A1 (en) 1999-07-30
ES2148525T3 (es) 2000-10-16
PL181042B1 (pl) 2001-05-31
EE9700029A (et) 1997-08-15
ATE195003T1 (de) 2000-08-15
DE69518156T2 (de) 2001-01-11
CN1216992C (zh) 2005-08-31
FI970009A (fi) 1997-03-04
PT769054E (pt) 2000-11-30
HUT76673A (en) 1997-10-28
SK161496A3 (en) 1997-08-06
RU2218348C2 (ru) 2003-12-10
US6159937A (en) 2000-12-12
NZ287406A (en) 1998-07-28
BR9508243A (pt) 1997-10-21
WO1996001318A1 (en) 1996-01-18
NO970020D0 (no) 1997-01-03
DE69518156D1 (de) 2000-08-31
NO970020L (no) 1997-03-05
CZ1497A3 (en) 1997-05-14
FI970009A0 (fi) 1997-01-02

Similar Documents

Publication Publication Date Title
HK1012416A1 (en) Immunomodulators
DE69512030D1 (en) Cerebral-dilator
DE59503739D1 (en) Polymer-sensor
DE69502271D1 (en) Afterabtrennung
DE69511086D1 (en) Pyrimidinderivate
DE69504528D1 (en) Quenchkühler
DE69429543D1 (en) Koagulationszange
GB2296033B (en) Handleset
DE59503634D1 (en) Friercontainer
EP0701109A3 (de) Wasserzähler
DE59509661D1 (en) Heterocyclylbenzonitrile
ZA9510671B (en) Thienopyridone
GB9415626D0 (en) Ethercan
AU122938S (en) Breadbox
GB9416026D0 (en) Flexigraze
DE69508761D1 (en) Haloalkylierungsverfahren
GB9405295D0 (en) Insert
DE59508136D1 (en) Phenylthio-oxazolin-derivate
DE69506730D1 (en) Differentialer antriebsmechanismus
SI0769054T1 (en) Immunomodulators
DE59503452D1 (en) Piezoresistiver widerstand
DE59510739D1 (en) N-cyanoaryl-stickstoffheterocyclen
DE69504062D1 (en) Spandexlieferspule
DE69502834D1 (en) Vinylperfluorcyclopropanpolymere
CA73798S (en) Air-purifier

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees